OSR Health (OSRHW) Operating Income (2024 - 2026)
OSR Health (OSRHW) posted Operating Income of -$3.7 million for Q1 2026, up 42.57% sequentially from -$6.4 million in Q4 2025, and down 25.68% YoY from -$4.9 million in Q1 2025.
OSR Health (OSRHW) Operating Income (2024 - 2026) Analysis & Trends
OSR Health has reported Operating Income for 3 years, with the latest figure at -$3.7 million in Q1 2026.
- Quarterly Operating Income fell 25.68% year-over-year to -$3.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$19.1 million (down 68.82% YoY) and the FY2025 annual result came in at -$18.3 million, down 56.85% from the prior year.
- Operating Income rose to -$3.7 million in Q1 2026 per OSRHW's latest filing, from -$6.4 million in the prior quarter.
- Over five years, Operating Income peaked at -$1.6 million in Q4 2024 and troughed at -$6.4 million in Q4 2025.
- A 3-year average of -$3.7 million and a median of -$3.6 million in 2024 frame the typical range for Operating Income.
- The widest YoY moves for Operating Income: up 11.65% in 2025, down 296.41% in 2025.
- Over 3 years, Operating Income stood at -$1.6 million in 2024, then slumped by 296.41% to -$6.4 million in 2025, then surged by 42.57% to -$3.7 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$3.7 million, -$6.4 million, and -$3.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.12 Bn | 131.27 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.30 Bn | 77.31 Bn | 3.93 Bn | 1.29 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.66 Bn | 1.37 Bn | 493.00 Mn |
| 4 | Moderna | 55.67 Bn | 50.53 Bn | 52.00 Mn | -815.00 Mn |
| 5 | BeOne Medicines | 41.43 Bn | 36.33 Bn | 1.53 Bn | 325.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | 231.44 Mn |
| 7 | BioNTech SE | 27.47 Bn | 9.08 Bn | 668.28 Mn | -375.75 Mn |
| 8 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 133.12 Mn |
| 9 | Insmed | 27.03 Bn | 25.87 Bn | 358.27 Mn | -1.55 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | -3.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.67 Mn |
| Dec 31, 2025 | -6.39 Mn |
| Sep 30, 2025 | -3.80 Mn |
| Jun 30, 2025 | -5.23 Mn |
| Mar 31, 2025 | -2.92 Mn |
| Dec 31, 2024 | -1.61 Mn |
| Sep 30, 2024 | -3.57 Mn |
| Jun 30, 2024 | -3.21 Mn |
| Mar 31, 2024 | -3.30 Mn |